Self-Management Data and Disease Progression in CKD
Official title: A Non-Interventional, Prospective Observational Study to Evaluate Disease Progression and Management Characteristics for the Development of an Integrated Self-Management Data Application in Chronic Kidney Disease
Run by Chungnam National University Hospital · NCT07754097 · Data updated 2026-11-12
This study tests whether patient-recorded self-management data collected via a mobile app can be linked to CKD progression in adults seen at a university hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years to 84 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Chungnam National University Hospital Academic / other |
| Locations | 1 site (Daejeon, DJ) |
| Status | Recruiting |
| Started | June 11, 2026 |
| Main results expected | June 11, 2029 |
| Study ends | June 11, 2029 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT07754097 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 19 to under 85 years with CKD or high risk for CKD requiring ongoing management, who can reliably use the mobile app to record self-management data and have HIS data accessible.
✕Probably not a fit
Patients who are unable to use the mobile app or whose CKD remains stable without recording changes may see limited personal benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective observational study enrolling adults with CKD or at high risk, who will use a mobile app to log self-management data alongside routine hospital data over 12 months. Researchers will collect home measurements, medication and diet logs, and HIS-derived clinical metrics to explore associations with disease progression and events such as acute kidney injury or hyperkalemia. Data will be analyzed for patterns between adherence to self-management and clinical outcomes, with user satisfaction assessed at 4, 8, and 12 months. No additional invasive procedures are performed beyond standard care, and all data are drawn from routine clinical Practice and patient-generated records.
Why it matters
Potential benefit: If successful, the approach could support better CKD self-management and help identify signals of progression to guide care.
How similar studies have gone: Prior work in digital self-management tools for chronic diseases has shown feasibility and some associations with outcomes, but this exact CKD-integrated mobile/HIS approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients aged 19 years or older and under 85 years. 2. Patients visiting the hospital for chronic kidney disease (CKD) management. 3. Patients diagnosed with CKD or identified as high-risk for CKD requiring continuous management (e.g., diabetes mellitus, hypertension, proteinuria, or decreased eGFR). 4. Patients capable of recording self-management data (blood pressure, diet, medication) independently or with assistance through the provided mobile application. 5. Patients whose clinical data can be collected from the Hospital Information System (HIS). Exclusion Criteria: 1. Patients who do not sign the informed consent form or lack the capacity to fully understand the study protocol and express voluntary consent. 2. Patients currently undergoing maintenance dialysis (hemodialysis or peritoneal dialysis) for end-stage kidney disease (ESKD). 3. Patients deemed unsuitable for participation in the study by the investigator.
Where it's running
-
Chungnam National University Hospital
Daejeon, Dj, South Korea Recruiting
Study contacts
- Study coordinator: Dae Eun Choi
- Email: daenii123@gmail.com
- Phone: +82-42-280-7141
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Periodontal Health in Rare Kidney Conditions and Controls
This study tests how common periodontitis is in people with rare kidney disorders and compares it to CKD patients and people without kidney disease.
-
AdiaVita regenerative therapy for chronic kidney disease
This trial tests whether AdiaVita (umbilical cord blood stem cells and exosomes plus glutathione) can improve kidney function in adults with stage 2–4 chronic kidney disease.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.